» Articles » PMID: 2966200

Mechanism of Protection from Graft-vs-host Disease in Murine Mixed Allogeneic Chimeras. I. Development of a Null Cell Population Suppressive of Cell-mediated Lympholysis Responses and Derived from the Syngeneic Bone Marrow Component

Overview
Journal J Immunol
Date 1988 May 1
PMID 2966200
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Splenocyte populations from whole body-irradiated recipients of mixed T cell-depleted (TCD) syngeneic and allogeneic (complete H-2 disparity) bone marrow, or of TCD syngeneic marrow alone, contain cells with the ability to suppress the generation of cell-mediated lympholysis responses in vitro. This activity, which is present by 8 days after bone marrow transplantation and persists for several weeks, has been analyzed for possible veto-like or other specificity. Although reproducible patterns of suppression were observed, depending both on host strain and on the genetic combination of the response examined, the overall suppression in vitro most closely resembles that which has been ascribed to "natural suppressor" cells in other systems. The suppression appears to be mediated by a non-T cell, non-B cell, nonadherent, asialo GM1-negative population. Cold target inhibition and CTL activity of chimeric cells have been ruled out as factors contributing to the observed suppression. Significantly, in mixed chimeras, suppression was found to be mediated exclusively by cells which were syngeneic to the recipient in both recipient strains tested. The rapid development of this suppressive activity may explain the resistance to graft-vs-host disease conferred on whole body-irradiated mice by the addition of TCD syngeneic marrow to an allogeneic graft-vs-host disease-producing inoculum.

Citing Articles

Double Negative T Regulatory Cells: An Emerging Paradigm Shift in Reproductive Immune Tolerance?.

Bafor E, Valencia J, Young H Front Immunol. 2022; 13:886645.

PMID: 35844500 PMC: 9283768. DOI: 10.3389/fimmu.2022.886645.


An Experience of Donor Lymphocyte Infusion after Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease.

Rostami T, Kiumarsi A Pediatr Rep. 2020; 12(3):149-154.

PMID: 33322370 PMC: 7768393. DOI: 10.3390/pediatric12030030.


Myeloid-Derived Suppressor Cells in the Context of Allogeneic Hematopoietic Stem Cell Transplantation.

dAveni M, Notarantonio A, Bertrand A, Boulange L, Pochon C, Rubio M Front Immunol. 2020; 11:989.

PMID: 32528476 PMC: 7256196. DOI: 10.3389/fimmu.2020.00989.


Lentiviral Fluorescent Genetic Barcoding for Multiplex Fate Tracking of Leukemic Cells.

Maetzig T, Ruschmann J, Sanchez Milde L, Lai C, von Krosigk N, Humphries R Mol Ther Methods Clin Dev. 2017; 6:54-65.

PMID: 28664166 PMC: 5480982. DOI: 10.1016/j.omtm.2017.05.007.


Gut toxicity during hemopoietic stem cell transplantation may predict acute graft-versus-host disease severity in patients.

Johansson J, Ekman T Dig Dis Sci. 2007; 52(9):2340-5.

PMID: 17415646 DOI: 10.1007/s10620-006-9404-x.